← SynDRA
CCT137690
SynDRA canonical compound SYN1970391 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | AURKA | AURKB | AURKC | FLT3 |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- CCT-137690
- 3-((4-(6-bromo-2-(4-(4-methylpiperazin-1-yl)phenyl)-3h-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)methyl)-5-methylisoxazole
- 6-Bromo-7-{4-[(5-Methylisoxazol-3-Yl)methyl]piperazin-1-Yl}-2-[4-(4-Methylpiperazin-1-Yl)phenyl]-1h-Imidazo[4,5-B]pyridine
- CHEMBL1236904
- 3-[[4-[6-bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-1H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]methyl]-5-methyl-1,2-oxazole
- 6-Bromo-7-[4-[(5-methyl-3-isoxazolyl)methyl]-1-piperazinyl]-2-[4-(4-methyl-1-piperazinyl)phenyl]-3H-imidazo[4,5-b]pyridine
- MLS006010283
- SCHEMBL4755249
- DTXSID30648898
- HMS3656D21
- BCP02554
- EX-A2038
- VTB38205
- BDBM50335609
- s2744
- ZINC58661275
- AKOS024458076
- AKOS026750563
- BCP9000498
- CCG-270006
- CS-0706
- SB19310
- NCGC00346676-01
- NCGC00346676-09
- NCGC00346676-11
- NCGC00346676-12
- AC-28465
- BS-14415
- HY-10804
- SMR004701353
- SW219481-1
- CCT137690, >=98% (HPLC)
- E98913
- J-002301
- Q27467783
- 6-Bromo-7-{4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazin-1-yl}-2-[4-(4-methylpiperazin-1-yl)phenyl]-1H-imidazo[4,5-b]pyridine
- YM4
Look up CCT137690 in the interactive SynDRA portal →